# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-025955
Filing Date
2026-08-05
Accepted
2026-08-05 17:01:01
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | tgtx20260630_10q.htm iXBRL | 10-Q | 1931204
2 | EXHIBIT 31.1 | ex_959226.htm | EX-31.1 | 12342
3 | EXHIBIT 31.2 | ex_959227.htm | EX-31.2 | 12686
4 | EXHIBIT 32.1 | ex_959228.htm | EX-32.1 | 5723
5 | EXHIBIT 32.2 | ex_959229.htm | EX-32.2 | 6040
| Complete submission text file | 0001437749-26-025955.txt |  | 7730823

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | tgtx-20260630.xsd | EX-101.SCH | 56065
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | tgtx-20260630_cal.xml | EX-101.CAL | 46486
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | tgtx-20260630_def.xml | EX-101.DEF | 398383
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tgtx-20260630_lab.xml | EX-101.LAB | 365641
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tgtx-20260630_pre.xml | EX-101.PRE | 429417
70 | EXTRACTED XBRL INSTANCE DOCUMENT | tgtx20260630_10q_htm.xml | XML | 1091564

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 261244582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)